Christine Hann

7PUBLICATIONS
23CO-AUTHORS
Image processingMolecular targetsCentral nervous systemPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 22, 2024
TooManyCellsInteractive: A visualization tool for dynamic exploration of single-cell data.

Conor Klamann, Christie J Lau, Javier Ruiz-Ramírez

|Nov 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance.

Magda Bahcall, Cloud P Paweletz, Yanan Kuang

|Jul 12, 2021
Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC.

Michael L Cheng, Christie J Lau, Marina S D Milan

|Dec 30, 2020
Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903).

Erin M Bertino, Ryan D Gentzler, Sarah Clifford

|Aug 04, 2019
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade.

Mohammad Rashidian, Martin W LaFleur, Vincent L Verschoor

Pageof 2